Literature DB >> 18220656

Diabetes-induced alterations in renal medullary microcirculation and metabolism.

Lina Nordquist1, Fredrik Palm.   

Abstract

Diabetes-induced renal complications, i.e. diabetes nephropathy, are a major cause of morbidity and mortality. The exact mechanisms mediating the negative influence of hyperglycemia on renal function are unclear, although several hypotheses have been postulated. Cellular mechanisms include glucose-induced excessive formation of reactive oxygen species, increased glucose flux through polyol pathway and pentose phosphate shunt, formation of advanced glycation end-products and activation of protein kinase C and NADPH oxidase. However, the renal effects in vivo of each and every one of these mechanisms are less clear, although recent studies have shown several major alterations predominantly in the renal medulla as a result of sustained hyperglycemia. Already during normal conditions, the renal medulla has a remarkably low oxygen tension (PO2) and a high degree of non-oxygen dependent energy metabolism. Alterations in either blood perfusion or oxygen delivery to the medullary region will have significant effects on both regional metabolism and total kidney function. Recently, sustained hyperglycemia has been shown to induce a pronounced reduction in preferentially renal medullary PO2. This review will present the current knowledge of diabetes-induced alterations in renal medullary metabolism and function, but also discuss future targets for prevention of diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18220656     DOI: 10.2174/157339907779802120

Source DB:  PubMed          Journal:  Curr Diabetes Rev        ISSN: 1573-3998


  7 in total

1.  Kidney hypoxia, attributable to increased oxygen consumption, induces nephropathy independently of hyperglycemia and oxidative stress.

Authors:  Malou Friederich-Persson; Erik Thörn; Peter Hansell; Masaomi Nangaku; Max Levin; Fredrik Palm
Journal:  Hypertension       Date:  2013-09-09       Impact factor: 10.190

2.  [Long-term therapy with propofol has no impact on microcirculation in medical intensive care patients].

Authors:  Christian Jung; Christoph Rödiger; Alexander Lauten; Michael Fritzenwanger; Bjoern Goebel; Julia Schumm; Hans-Reiner Figulla; Markus Ferrari
Journal:  Med Klin (Munich)       Date:  2009-05-16

3.  Detection of localized changes in the metabolism of hyperpolarized gluconeogenic precursors 13 C-lactate and 13 C-pyruvate in kidney and liver.

Authors:  Cornelius von Morze; Gene-Yuan Chang; Peder E Z Larson; Hong Shang; Prasanna K R Allu; Robert A Bok; Jason C Crane; Marram P Olson; Chou T Tan; Irene Marco-Rius; Sarah J Nelson; John Kurhanewicz; David Pearce; Daniel B Vigneron
Journal:  Magn Reson Med       Date:  2016-04-21       Impact factor: 4.668

Review 4.  The Tubulointerstitial Pathophysiology of Progressive Kidney Disease.

Authors:  H William Schnaper
Journal:  Adv Chronic Kidney Dis       Date:  2017-03       Impact factor: 3.620

5.  Protective role of PGC-1α in diabetic nephropathy is associated with the inhibition of ROS through mitochondrial dynamic remodeling.

Authors:  Kaifeng Guo; Junxi Lu; Yan Huang; Mian Wu; Lei Zhang; Haoyong Yu; Mingliang Zhang; Yuqian Bao; John Cijiang He; Haibing Chen; Weiping Jia
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

6.  Age, kidney function, and risk factors associate differently with cortical and medullary volumes of the kidney.

Authors:  Xiangling Wang; Terri J Vrtiska; Ramesh T Avula; Leah R Walters; Harini A Chakkera; Walter K Kremers; Lilach O Lerman; Andrew D Rule
Journal:  Kidney Int       Date:  2013-09-25       Impact factor: 10.612

7.  Early diabetic kidney maintains the corticomedullary urea and sodium gradient.

Authors:  Haiyun Qi; Thomas S Nørlinger; Per M Nielsen; Lotte B Bertelsen; Emmeli Mikkelsen; Yafang Xu; Hans Stødkilde Jørgensen; Christoffer Laustsen
Journal:  Physiol Rep       Date:  2016-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.